Korea Pharma Co., Ltd. (032300) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Korea Pharma Co., Ltd. (032300:KRX), powered by AI.

Current Price
₩8,930
P/E Ratio
-37.0
Market Cap
97.6B
Sector
Healthcare
What is the Korea Pharma Co., Ltd. stock price forecast?

Korea Pharma Co., Ltd. is currently trading at ₩8,930. View real-time AI analysis on Alpha Lenz.

What is Korea Pharma Co., Ltd. insider trading activity?

View the latest insider trading data for Korea Pharma Co., Ltd. on Alpha Lenz.

What is Korea Pharma Co., Ltd.'s P/E ratio?

Korea Pharma Co., Ltd.'s P/E ratio is -37.0.

Korea Pharma Co., Ltd.

KRX · 032300
₩8,930-20(-0.22%)Market closedKRX regular session 09:00–15:30 KST
Ask about Korea Pharma Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Korea Pharma Co., Ltd. trades at a P/E of -37.0 (undervalued) with modest ROE of -3.8%.

Ask for details

Company Overview

Korea Pharma Co., Ltd. is a prominent entity in the pharmaceutical industry, primarily focused on the research, development, and production of high-quality pharmaceutical products. The company specializes in a wide array of medications, including prescription drugs and over-the-counter treatments, catering to various health needs and conditions. Korea Pharma Co., Ltd. is known for its commitment to innovation in pharmaceutical technologies, contributing significantly to advancements in medicine. It serves diverse markets encompassing hospitals, pharmacies, and direct consumer sales channels. The company plays a crucial role in the healthcare sector, enhancing accessibility to essential medicines and meeting the growing demand for healthcare solutions in South Korea and beyond. As an integral player in the pharmaceutical landscape, Korea Pharma actively participates in improving healthcare standards through rigorous quality control and compliance with international health regulations. Its efforts in pharmaceutical research and production uphold the company’s reputation as a trustworthy provider of medicinal products and solutions.

CEO박은희
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

₩97,614,973,950Market Cap
₩87,601,377,060Revenue
10.91MShares Out
0Employees

Margins

35.85%Gross
3.11%EBITDA
-1.01%Operating
-5.16%Pre-Tax
-3.01%Net

Valuation

-36.97P/E
1.42P/B
1.11EV/Sales
40.07EV/EBITDA
72.07P/FCF

Growth (CAGR)

2.63%Rev 3Yr
4.14%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-2.21%ROA
-3.77%ROE
-0.80%ROIC

Financial Health

₩27,529,786,340Cash & Cash Equivalents
₩30,324,372,880Net Debt
84.11%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Korea Pharma Co., Ltd. (ticker: 032300) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $97.6B.

The current price is ₩8,930 with a P/E ratio of -36.97x and P/B of 1.42x.

ROE is -3.77% and operating margin is -1.01%. Annual revenue is $87.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Korea Pharma Co., Ltd. (032300) Stock Forecast 2026 ₩8,930 — Price, Financials & Analyst Targets | Alpha Lenz